STAT

OCTOBER 21, 2024

If you were hoping to see where ultra-processed foods might fit in the next Dietary Guidelines for Americans, hold that thought. Scientific experts tasked with advising federal officials drafting the 2025-2030 Dietary Guidelines for Americans said the data were far too limited to draw conclusions. Meeting Monday, the first of two days of presentations, they discussed research findings to inform a report to the Department of Health and Human Services and the Department of Agriculture.

362

362

PharmaVoice

OCTOBER 21, 2024

Providers struggle with time-consuming processes. Patients are waiting for therapy. Embedded EMR system solutions can streamline therapy initiation and improve outcomes.

246

246

STAT

OCTOBER 21, 2024

STAT is publishing this investigation in partnership with The Examination. Perham Gorji was a career government lawyer, helping to lead the Food and Drug Administration’s battle against tobacco and e-cigarettes.  He was there as the agency contemplated a ban on menthol cigarettes, and as vapes of all shapes and sizes flooded the market, hooking a new generation on nicotine.

355

355

PharmaVoice

OCTOBER 21, 2024

After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders.

Compounding 173

Compounding Diabetes 173

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

OCTOBER 21, 2024

Confounding data from a Pfizer clinical trial has rattled the field of gene therapy for Duchenne muscular dystrophy, raising more questions about the regulatory standard used to approve a treatment from Sarepta Therapeutics, and complicating plans for other companies hoping to develop next-generation products.  Scientifically, Pfizer’s gene therapy did what it was supposed to do.

350

350

ALiEM - Pharm Pearls

OCTOBER 21, 2024

A 5-year-old generally healthy fully immunized boy presented to the ED with worsening left ear redness, swelling, and tenderness that his family noticed the day before presentation. His family had also recently noticed an abrasion over that ear. The patient was on amoxicillin for strep throat, which was diagnosed a week before the onset of his symptoms and was improving.

Medical Schools 169

Medical Schools Immunization Immunity 169

PharmaVoice

OCTOBER 21, 2024

PMRs are not new but drug developers can use AI to predict risk and manage costs earlier in studies.

Drug Development 130

Drug Development 130

STAT

OCTOBER 21, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine.  Sign up  to get it in your inbox every Monday. The ‘#1 PRIORITY’ The emails from inside a physician practice owned by UnitedHealth Group sounded cheery, but were all business.

Drug Development 341

Drug Development 341

The Pharmacist

OCTOBER 21, 2024

IT suppliers are testing pharmacy access to GP records with some pharmacies using Cegedim Rx live in a pilot stage, it has been revealed. Speaking at the Pharmacy Show earlier this month, Tahmina Rokib, clinical lead at the clinical digital informatics, transformation directorate at NHS England (NHSE) said that Cegedim had been running a pilot […] The post Pharmacies piloting access to GP records appeared first on The Pharmacist.

124

124

STAT

OCTOBER 21, 2024

A coalition of 12 Philadelphia-area health systems announced Monday that its members have abandoned the use of race adjustments in four clinical tools commonly used to guide care, a move that health leaders say will improve treatment and prevent delays in diagnosis for Black, Hispanic, and Asian patients.  The decision marks one of the largest and broadest efforts to date to remove race from widely used clinical algorithms.

Hospitals 333

Hospitals 333

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

OCTOBER 21, 2024

An antiretroviral combination developed by Gilead and MSD suppressed HIV with a single weekly oral dose in a phase 2 trial reported at IDWeek 2024

122

122

STAT

OCTOBER 21, 2024

Does it make sense for a chain of drug stores to own a major health insurance company? That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer Aetna. The biggest pharmacy chain in the U.S. had already been moving beyond retail since its 2007 deal for pharmacy benefit manager Caremark.

Health Insurance Companies 329

Health Insurance Companies 329

Pharma Times

OCTOBER 21, 2024

Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK

118

118

STAT

OCTOBER 21, 2024

I have lost babies. Well, I didn’t lose them per se. They haven’t been misplaced, like keys or something. To forgo the polite euphemisms, they died after 20 weeks.  I felt isolated, devastated, and like there wasn’t a vocabulary for what happened — clinically, emotionally, or legally.

308

308

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

OCTOBER 21, 2024

Two digital therapeutics for addiction are available again through PursueCare, which acquired them from now-defunct Pear Tx last year

115

115

STAT

OCTOBER 21, 2024

Compared to molecular techniques to study single cells, images feel a little like “old school biology,” says Anne Carpenter, an artificial intelligence and cell biology researcher at the Broad Institute. Yet  images are a gold mine that can yield information as rich as the genome — once you learn how to extract it.  Carpenter is using AI and other computational methods to do exactly that, helping to propel an AI-driven boom in cell biology and medicine over the pas

306

306

Pharma Times

OCTOBER 21, 2024

The five new programmes are designed to fit alongside full-time work and clinical practice

115

115

STAT

OCTOBER 21, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Have you ever seen an award-winning journalist sing karaoke? After the Summit ended last week, a big group of STAT staffers belted and crooned together for hours and my heart has never been so full. It was all deeply off the record so I can’t tell you who sang what.

283

283

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

OCTOBER 21, 2024

Seaport Therapeutics completes a $225m Series B to fund its improved therapies for depression and anxiety, just months after raising $100m on its debut

115

115

STAT

OCTOBER 21, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that oh-so familiar routine of online meetings, calls, and deadlines has predictably returned. To cope, we are firing up the coffee kettle in the Pharmalot cafeteria and brewing another cup of stimulation. Our choice today is the seasonal pumpkin spice.

Vaccines 278

Vaccines Communication 278

The Pharmacist

OCTOBER 21, 2024

Pharmacists, other health professionals and the general public have been invited to respond to a national 'engagement exercise' to help shape the government's 10-year plan for the NHS. Prime Minister Sir Keir Starmer said today that while the government has 'a clear plan to fix the health service', it was 'only right that we hear […] The post Pharmacists asked to help shape NHS 10-year plan appeared first on The Pharmacist.

111

111

STAT

OCTOBER 21, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Morning! Today, we discuss why disappointing data from Pfizer’s Duchenne muscular dystrophy trial might spell trouble for others developing gene therapies for the condition.

Drug Pricing 269

Drug Pricing Drug Development 269

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

BioPharma Dive

OCTOBER 21, 2024

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

105

105

STAT

OCTOBER 21, 2024

Catalent, a leading contract drug manufacturer, issued an open letter on Monday to reassure customers that a proposed $16.5 billion deal — in which it would be acquired by Novo Nordisk’s parent — will not raise competitive concerns or diminish its ability to provide services to other drug companies. Catalent is an attractive buyout target for Novo Holdings — which owns 77% of the voting shares in the drugmaker — because it is currently a subcontractor that

Drug Pricing 260

Drug Pricing Drug Development 260

PharmaTech

OCTOBER 21, 2024

Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.

105

105

STAT

OCTOBER 21, 2024

During her time at the helm of CVS Health, former chief executive Karen Lynch often placed her complicated family history at the center of her argument for why she wanted to reinvent her company — and with it the way that health care is delivered in America. Lynch regularly told the story of her traumatic youth with a vulnerability uncharacteristic of most corporate leaders.

254

254

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

OCTOBER 21, 2024

The pharmaceutical industry is a significant contributor to the global economy, with a substantial portion of its production costs incurred during the development stage. This makes intellectual property protection crucial for the industry’s success.

105

105

Express Pharma

OCTOBER 21, 2024

Johnson & Johnson ‘s subcutaneous (SC) Tremfya (guselkumab) demonstrated strong results in the Phase III GRAVITI trial, marking a major breakthrough in the treatment of Crohn’s disease (CD). This patient-friendly regimen could enhance patient autonomy, improve adherence, and lead to better outcomes. The GRAVITI results position guselkumab as a significant new option in CD, says GlobalData.

105

105

pharmaphorum

OCTOBER 21, 2024

Novo Nordisk's TFPI drug concizumab has been backed for approval in the EU to prevent bleeding episodes in people with haemophilia and inhibitors

105

105

Pharmaceutical Technology

OCTOBER 21, 2024

This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to restore vision in patients with retinitis pigmentosa (RP).

98

98

BioPharma Dive

OCTOBER 21, 2024

Learn how Syngene’s integrated strategy can enhance your mAb production capabilities.

98

98